Biogen Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Biogen Inc's ROI in the third quarter of 2026?
Biogen Inc achieved a return on average invested assets (ROI) of 1.27 % in its third quarter of 2026, which is below Biogen Inc's average return on investment, which stands at 13.99%.

ROI decreased relative to the period ending Jun 30 2026, due to the decline in net income.

Within the Healthcare sector 97 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2026 quarter, so far to 1396, from total ROI ranking in the second quarter of 2026 at 1646.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Investment Change TTM	13.23 %	14.51 %	13.03 %	8.23 %	3.19 %
Y / Y Net Income Change TTM	-78.4 %	-45.47 %	53.17 %	97.33 %	314.03 %
Investment (TTM) in Millions	28,156	28,170	26,484	26,257	25,918
Return On Investment (TTM)	1.27 %	3.13 %	5.29 %	5.17 %	6.68 %
BIIB's Overall Ranking	# 1396	# 1646	# 1094	# 1105	# 1135
Seq. Investment Change TTM	2.1 %	2.91 %	3.75 %	3.88 %	3.25 %
Seq. Net Income Change TTM	-58.36 %	-39.16 %	6.11 %	-19.62 %	5.1 %
Net Income (TTM) in Millions	348	835	1,372	1,293	1,609

BIIB Company Profile >> Back to BIIB Roi Comparisons >> See Annual BIIB Return On Investment

Return On Investment BIIB's Ranking
Within:	No.
Industry	# 12
Sector	# 98
Overall	# 1396

Return On Investment Statistics
High	Average	Low
27.48 %	13.99 %	0.45 %
(Jun 30 2020)		(June 30. 2006)

Financial Statements
Biogen Inc's III. Quarter Investments	$ 28,156 Millions	BIIB's Balance sheet
Biogen Inc's III. Quarter Income	$ -21 Millions	Quarterly BIIB's Income Statement
BIIB's Income by Division		See BIIB's Income by Division

BIIB Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	26,090	22,521	23,411	21,272	19,643
Y / Y Investment Growth	15.85 %	-3.8 %	10.05 %	8.29 %	-5.85 %
Net Income in Millions	1,293	1,632	1,162	2,962	1,728
Y / Y Net Income Growth	-20.79 %	40.53 %	-60.78 %	71.43 %	-57.45 %
Annual Return On Investment	4.96 %	7.25 %	4.96 %	13.92 %	8.8 %

Annual Roi Comment

In the fiscal year 2025 ROI decreased relative to the previous year to 4.96 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BIIB's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BIIB's Competitors
Subscribers only: Roi for Biogen Inc's Suppliers
Subscribers only: Return On Investment for BIIB's Customers

Other Ratios
BIIB's Roa	BIIB's Inventory Turnover Ratio	BIIB's Growth Rates	BIIB's Dividend Statistics
	BIIB's Profitability Ratios	BIIB's Asset Turnover Ratio	BIIB's Dividend Growth
BIIB's Roe	BIIB's Valuation Ratios	BIIB's Financial Strength Ratios	BIIB's Dividend Payout Ratio

Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector	ROI
U S Physical Therapy Inc	3.33 %
Conmed Corporation	3.16 %
Integer Holdings Corporation	3.13 %
Avantor Inc	3.11 %
Innovage Holding Corp	2.95 %
Ligand Pharmaceuticals Incorporated	2.84 %
Revvity Inc	2.35 %
Pfizer Inc	2.34 %
Jazz Pharmaceuticals Plc	2.12 %
Teva Pharmaceutical Industries Limited	1.96 %
Icu Medical Inc	1.74 %
Biogen Inc	1.26 %
Community Health Systems Inc	1.03 %
Waters Corporation	0.51 %
Integra Lifesciences Holdings Corp	0.31 %

Date modified: 2026-10-29T17:22:33+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.